EPIQ Partners’s CVS Health CVS Stock Holding History

EPIQ Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,000	Closed	-$355K	–	78
2020 Q3	$355K	Buy	+6,000	New	+$373K	0.27%	55

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EPIQ Partners's CVS Position: Q4 2020 in Review

EPIQ Partners sold out of CVS Health (CVS) in Q4 2020, closing a stake of 6,000 shares — an estimated $355K sold.

EPIQ Partners first reported a position in CVS in Q3 2020 and held it in 1 quarter. The position peaked at $355K in Q3 2020. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

EPIQ Partners reported no remaining CVS Health position as of Q4 2020 after selling out during the quarter.
EPIQ Partners sold 6,000 CVS Health shares in Q4 2020, an estimated $355K.
EPIQ Partners first reported a position in CVS Health in Q3 2020 and held it in 1 quarter.
EPIQ Partners's CVS Health position peaked at $355K in Q3 2020.
1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on EPIQ Partners's 13F filing for Q4 2020, filed 11 Jan 2021.